Concepedia

Aliyah Pabani

AP

Statistics

Publications

16

Citations

1.5K

H-Index

15

Active since

2019

Affiliations

University of Calgary(Current)

University of Alberta

Alberta Health Services

Johns Hopkins University

Columbia University Irving Medical Center

Aliyah Pabani is an author at University of Calgary specializing in oncology, cancer immunotherapy, and immunotherapy.

Publications per year

2019–2024

16

Publications

16

Neoadjuvant atezolizumab and chemotherapy in patients with resectable non-small-cell lung cancer: an open-label, multicentre, single-arm, phase 2 trial

Catherine A. Shu, Justin F. Gainor, Mark M. Awad et al. · The Lancet Oncology · 2020 · 640 citations

Medicine, Oncology, Pharmacology +14

Treatment Outcomes of Immune-Related Cutaneous Adverse Events

Gregory S. Phillips, Jennifer Wu, Matthew D. Hellmann et al. · Journal of Clinical Oncology · 2019 · 235 citations · Full text

Medicine, Dermatology, Immunology +17

Immune-Related Adverse Events and Survival Among Patients With Metastatic NSCLC Treated With Immune Checkpoint Inhibitors

Sarah Cook, Vanessa Samuel, Daniel E. Meyers et al. · JAMA Network Open · 2024 · 152 citations · Full text

Life Sciences, Immunology, Oncology +16

The Lung Immune Prognostic Index Discriminates Survival Outcomes in Patients with Solid Tumors Treated with Immune Checkpoint Inhibitors

Daniel E. Meyers, Igor Stukalin, Isabelle A. Vallerand et al. · Cancers · 2019 · 76 citations · Full text

Medicine, Immunology, Oncology +17

Association of Immune-Related Adverse Events, Hospitalization, and Therapy Resumption With Survival Among Patients With Metastatic Melanoma Receiving Single-Agent or Combination Immunotherapy

Alexander Watson, Siddhartha Goutam, Igor Stukalin et al. · JAMA Network Open · 2022 · 65 citations · Full text

Life Sciences, Immunology, Oncology +15

1–5 of 16